InvestorsHub Logo
Post# of 252687
Next 10
Followers 13
Posts 325
Boards Moderated 0
Alias Born 01/15/2008

Re: DewDiligence post# 112882

Thursday, 01/20/2011 1:06:20 PM

Thursday, January 20, 2011 1:06:20 PM

Post# of 252687
Mr. Mann has lost all credence at credibility, and for nothing! Unless his intent was to allow a window of opportunity for insiders to get out. He is the biggest insider and did not get out. So other than it being a congenital character defect, it is hard to understand any other motivation, as the FDA decision was going to determine the share price, not some fluff from Mr. Mann. Why even participate in such trite?

He held the dang CR letter for an entire day! And then he did not release it until after close of the market, while it traded all day, until a short attack which was obviously caused by a leak.

Worldcoms CEO lied to the world, straight-faced, just weeks before the company fell. I saw that on CNBC. Clearly a congenital character defect there to enable anyone to be able to do that as he did, Mr. Mann (not in WCOM's league - no intent to say he is) but clearly he has some of that promoter aspect to him that makes the words he say much more acune to a Teva statement on tLovenox or mcopaxone.

I however very much doubt that Teva would withold a CR letter of this significance in this manner.

The more you think of it, the more this MNKD action really sucks, and the more that I should have bought some puts (and a lot of puts on this binary decision). I had not followed MNKD very close before, and things came up quickly, but that should have been my first use of going short (via naked puts), as there was just no way that attempting to prove bioequivalence with a new device so late in the process was ever going to get past the FDA.

Operational and PR issues to say the least.

Tinker
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.